Clinical Trials Directory

Trials / Completed

CompletedNCT01539486

Relationship of Preoperative Parathyroid Hormone (PTH) and Ex-Vivo Gamma Counts in Minimally Invasive Parathyroidectomy

Relationship of Preoperative PTH and Ex-Vivo Gamma Counts in Minimally Invasive Parathyroidectomy

Status
Completed
Phase
Study type
Observational
Enrollment
29 (actual)
Sponsor
University of Arkansas · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The intent for this study is to do a retrospective chart review of all patients who have undergone minimally invasive parathyroidectomy for primary hyperthyroidism. All data collected will be recorded under assigned identification numbers that will have no association with medical record or hospital numbers. Identifying characteristics will include age and sex. Anonymity will be upheld. The patient/family will not be contacted directly. All information will be obtained from the medical chart. Demographics, location, preoperative PTH levels and intraoperative Ex-Vivo gamma counts, co-morbid conditions, and the outcome based on the hospital notes will be obtained from patients' charts and will be transferred to a secure database. It is our hypothesis that there is a linear relationship between immediate preoperative parathyroid hormone (PTH) levels and Ex-Vivo gamma counts and the aim of this study is to better describe this relationship.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2012-02-27
Last updated
2023-09-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01539486. Inclusion in this directory is not an endorsement.